
LIN · NASDAQ-GS
Linde sells industrial gases and related engineering services. Its gas operations serve customers across the Americas, EMEA and Asia-Pacific, with demand linked to industrial activity, electronics and healthcare; engineering work includes large projects that add to its backlog. The evidence does not provide revenue shares by segment. Linde reports $34.0 billion of FY2025 revenue and $6.9 billion of net income, compared with $33.0 billion and $6.6 billion, respectively, in FY2024. In Q3 2026, it reports sales of $9.4 billion and adjusted EPS of $4.59, supported by pricing and volume growth.
Linde fell $7.21, or 1.41%, from $510.36 to $503.15 over the reported period. The stock edged down into the week, rose slightly on Tuesday, then slipped on Wednesday and dropped more sharply on Thursday, when Q3 results were reported. The results beat estimates: adjusted EPS was $4.59, up 9% year over year, with coverage pointing to higher Americas pricing and volumes and strong electronics demand. The market response was negative despite those results; fourth-quarter guidance was described as near expectations, and coverage differs on whether the full-year outlook was maintained or raised. Linde’s $7.9 billion project backlog and restructuring plans supported the growth case, but did not prevent the late-week decline.
Linde rose 3.30%, from $487.35 to $503.44, across the displayed October 12–19 span. The stock advanced at every listed close, with no material within-period reversal: it gained from $487.35 on October 12 to $492.11 on October 13, then continued higher to $498.43 on October 16 and $503.44 on October 19. Volume was highest on October 15 at 2.55 million shares and eased to 1.72 million on October 19. No supplied evidence ties the advance to a new company announcement. Coverage focused instead on the October 29 earnings release and expectations for year-over-year growth; the evidence does not establish that this outlook drove the move or provide market benchmarks to explain it.
Linde rose 1.03%, from $482.38 on October 5 to $487.35 on October 12. Shares jumped to $489.95 on October 6, then surrendered that gain over the next two sessions, closing at $481.70 on October 8, before recovering on October 9 and October 12. The supplied evidence does not establish a specific event as the cause of the move: it includes an RBC target reduction and Bernstein’s reiterated rating, but provides no dates that tie either item to the trading sessions. Nor does it provide market or sector performance for comparison. The net gain therefore came amid a sharp early-week rise and retracement, followed by a modest recovery, without a clearly attributable weekly catalyst.
LIN rose 3.50% over the supplied price window, from $473.37 on September 29 to $489.95 on October 6. The main company-specific backdrop in the evidence was investor interest in electronics and semiconductor demand: coverage highlighted an $8.1 billion electronics backlog and AI-chip demand, while BMO reiterated Outperform on the electronics outlook. The shares first edged up, then fell from $474.65 on September 30 to $469.45 on October 1 before rebounding to $479.48 on October 2; gains continued on October 5 and 6. Bernstein also reiterated its rating, citing space-business growth. The evidence does not establish that these reports directly caused the move, and it supplies no broader market data to separate company news from market effects.
Linde shares rose 0.28%, from $468.14 to $469.45, over the reported week. The stock advanced from $472.04 on Monday, September 28, to $474.65 on Wednesday, extending gains across the first three sessions; it then reversed sharply, falling $5.20 to $469.45 on Thursday, October 1, and giving back most of that advance. The supplied evidence contains no dated company-specific news explaining the trading pattern, and it provides no market benchmark with which to attribute the move to broader conditions. Argus Research's target reduction is mentioned, but no date is supplied, so it cannot be tied to this week's price action.
Linde rose 1.65%, from $462.09 to $469.72, over the stated week. The move was uneven: shares fell to $457.50 on Monday, September 21, then rebounded over the next two sessions, gaining to $464.91 on Tuesday and $469.72 on Wednesday. That recovery more than reversed the early-week decline. The supplied evidence does not identify a company-specific announcement or a broad market event that explains the move. Although the article list includes coverage of Linde’s dividend and valuation, it provides no dated developments tying those topics to this week’s trading. The stock therefore advanced without an identifiable catalyst in the supplied evidence.
Linde fell $21.20, or 4.33%, from $489.58 to $468.38 over the reported period. The shares slipped through the first four sessions, reaching $477.57 on September 4, before falling another 1.9% to $468.38 on September 8, with volume rising to 2.58 million. The main company-specific pressure was concern over soft third-quarter guidance, highlighted in coverage following record results. Bernstein SocGen also cut its price target after project analysis. Additional commentary cited higher capital expenditure and stronger peer momentum as limiting upside, while separate reports said macroeconomic data was influencing trading. There was no material within-period reversal; selling accelerated into the final session.
Linde fell 0.65% over the week, from $485.35 to $482.19. The shares initially strengthened, closing at $489.51 on August 28 and $489.58 on August 31, before slipping to $486.76 on September 1 and recovering slightly to $487.45 on September 2. Thursday’s sharper decline coincided with Linde trading ex-dividend for its $1.60 quarterly payment, while an ETF Channel report also identified LIN among stocks affected by ETF outflows. Earlier coverage emphasized the company’s guidance, dividend support and second-quarter earnings beat, but those factors did not prevent the late-week reversal. No new company-specific earnings release or analyst action was supplied for the week.
Linde rose $1.94, or 0.40%, over the week, from $487.57 on August 21 to $489.51 on August 28. Trading was volatile rather than directional: the stock gained $2.46 on Monday, gave back $2.83 on Tuesday, recovered $3.13 on Wednesday, fell $4.98 on Thursday, and rebounded $4.16 on Friday. The supplied evidence contains no dated company-specific announcement, earnings release, or guidance change explaining those reversals. The only potentially relevant flow item was BNK Invest’s report highlighting ETF share-count changes involving LIN, although its snippet quantified the inflow for SCHG rather than Linde specifically. Overall, the stock moved modestly higher without a clear company catalyst.
Linde rose $12.00, or 2.50%, from $480.46 on August 3 to $492.46 on August 10. The advance was concentrated early: the stock gained $4.18 on Tuesday and another $6.41 on Wednesday, reaching $491.05. It then gave back modest ground on Thursday and Friday, closing at $490.11 and $489.98, before adding $2.48 on Monday. The supplied evidence identifies no company-specific announcement, earnings release, contract, executive change, or current analyst action that explains the move. Trading therefore appears to have reflected market positioning or broader conditions, although no specific market catalyst or index performance is provided. Volume declined from 2.8 million shares on August 3 to 1.9 million on August 10.
Linde fell $26.54, or 5.19%, from $511.18 to $484.64 over the period, with the decline concentrated on Friday, when shares dropped $30.26 to $478.38 on volume of 5.22 million. The selloff coincided with Linde’s release of second-quarter results, which nevertheless showed record sales, an adjusted EPS beat, and a record $8.1 billion sale-of-gas project backlog. The company also announced a long-term ultra-high-purity-gas contract with a major semiconductor manufacturer and plans to invest $1 billion in an Arizona facility expansion. Shares stabilized afterward, rising 0.4% on Monday and 0.9% on Tuesday, but those gains recovered only a small portion of Friday’s loss. The supplied evidence does not identify a negative company-specific catalyst explaining the market reaction.